Hsp70 interactions with the p53 tumour suppressor protein
暂无分享,去创建一个
F. King | M. Żylicz | A. Wawrzynów | M Zylicz | F W King | A Wawrzynow | Frank W. King | Maciej Zylicz | Frank W King | Alicja Wawrzynow | Frank W King | Alicja Wawrzynow
[1] T. Rapoport,et al. J proteins catalytically activate Hsp70 molecules to trap a wide range of peptide sequences. , 1998, Molecular cell.
[2] Dick D. Mosser,et al. Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome , 2000, Nature Cell Biology.
[3] J. Shay,et al. A temperature‐sensitive mutant of human p53. , 1994, The EMBO journal.
[4] W. Pratt,et al. Reconstitution of the Steroid Receptor·hsp90 Heterocomplex Assembly System of Rabbit Reticulocyte Lysate* , 1996, The Journal of Biological Chemistry.
[5] P. Jeffrey,et al. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. , 1994, Science.
[6] O. Halevy,et al. Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53 , 1990, Cell.
[7] C. Georgopoulos,et al. The dnaK protein of Escherichia coli possesses an ATPase and autophosphorylating activity and is essential in an in vitro DNA replication system. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[8] F. Hartl,et al. Principles of protein folding in the cellular environment. , 1999, Current opinion in structural biology.
[9] P. Howley,et al. In vivo ubiquitination and proteasome-mediated degradation of p53(1). , 1996, Cancer research.
[10] Holger Sondermann,et al. Structure of a Bag/Hsc70 Complex: Convergent Functional Evolution of Hsp70 Nucleotide Exchange Factors , 2001, Science.
[11] C. Harris,et al. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. , 1994, Cancer research.
[12] P. Sutphin,et al. The Physical Association of Multiple Molecular Chaperone Proteins with Mutant p53 Is Altered by Geldanamycin, an hsp90-Binding Agent , 1998, Molecular and Cellular Biology.
[13] R. Reddel,et al. Inactivation of Tumor Suppressor p53 by Mot-2, a hsp70 Family Member* , 1998, The Journal of Biological Chemistry.
[14] S. Jentsch,et al. GrpE‐like regulation of the Hsc70 chaperone by the anti‐apoptotic protein BAG‐1 , 1997, The EMBO journal.
[15] U. Moll,et al. Cytoplasmic sequestration of wild-type p53 protein impairs the G1 checkpoint after DNA damage , 1996, Molecular and cellular biology.
[16] K. Wiman,et al. Reactivation of Mutant p53 through Interaction of a C-Terminal Peptide with the Core Domain , 1999, Molecular and Cellular Biology.
[17] T. Force,et al. Hsp72-Mediated Suppression of c-Jun N-Terminal Kinase Is Implicated in Development of Tolerance to Caspase-Independent Cell Death , 2000, Molecular and Cellular Biology.
[18] D. Lane,et al. Strategies for manipulating the p53 pathway in the treatment of human cancer. , 2000, The Biochemical journal.
[19] C. Georgopoulos,et al. The Escherichia coli DnaK chaperone, the 70-kDa heat shock protein eukaryotic equivalent, changes conformation upon ATP hydrolysis, thus triggering its dissociation from a bound target protein. , 1991, The Journal of biological chemistry.
[20] R. Morimoto,et al. Role of the heat shock response and molecular chaperones in oncogenesis and cell death. , 2000, Journal of the National Cancer Institute.
[21] P. Sutphin,et al. Geldanamycin-stimulated destabilization of mutated p53 is mediated by the proteasome in vivo , 1997, Oncogene.
[22] B. Groner,et al. Restoration of the growth suppression function of mutant p53 by a synthetic peptide derived from the p53 C-terminal domain , 1997, Nature Medicine.
[23] F. Hartl,et al. Hip, a novel cochaperone involved in the eukaryotic hsc70/hsp40 reaction cycle , 1995, Cell.
[24] Jong-il Kim,et al. T Cell Lymphoma in Transgenic Mice Expressing the HumanHsp70Gene , 1996 .
[25] R. Morimoto,et al. Bag1–Hsp70 mediates a physiological stress signalling pathway that regulates Raf-1/ERK and cell growth , 2001, Nature Cell Biology.
[26] Jonathan J. Lewis,et al. Immunization of cancer patients with autologous cancer‐derived heat shock protein gp96 preparations: A pilot study , 2000, International journal of cancer.
[27] M. Jäättelä. Over‐expression of hsp70 confers tumorigenicity to mouse fibrosarcoma cells , 1995, International journal of cancer.
[28] D R Ciocca,et al. Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer: prognostic implications. , 1993, Journal of the National Cancer Institute.
[29] S. Gottesman,et al. Posttranslational quality control: folding, refolding, and degrading proteins. , 1999, Science.
[30] J. Sambrook,et al. Common and divergent peptide binding specificities of hsp70 molecular chaperones. , 1994, The Journal of biological chemistry.
[31] W. Welch. Mammalian stress response: cell physiology, structure/function of stress proteins, and implications for medicine and disease. , 1992, Physiological reviews.
[32] R. Anderson,et al. A hitchhiker's guide to the human Hsp70 family. , 1996, Cell stress & chaperones.
[33] S. Horinouchi,et al. A Role for Hsc70 in Regulating Nucleocytoplasmic Transport of a Temperature-sensitive p53 (p53Val-135)* , 2001, Journal of Biological Chemistry.
[34] R. Morimoto,et al. The Chaperone Function of hsp70 Is Required for Protection against Stress-Induced Apoptosis , 2000, Molecular and Cellular Biology.
[35] P. Srivastava,et al. Natural autoantibodies against heat‐shock proteins hsp70 and gp96: implications for immunotherapy using heat‐shock proteins , 2000, Immunology.
[36] L Rensing,et al. Chaperones in cell cycle regulation and mitogenic signal transduction: a review , 2000, Cell proliferation.
[37] M. Żylicz,et al. Divergent Effects of ATP on the Binding of the DnaK and DnaJ Chaperones to Each Other, or to Their Various Native and Denatured Protein Substrates (*) , 1995, The Journal of Biological Chemistry.
[38] K. Flaherty,et al. 7 Stress-70 Proteins and Their Interaction with Nucleotides , 1994 .
[39] W. Kelley,et al. The J-domain family and the recruitment of chaperone power. , 1998, Trends in biochemical sciences.
[40] C. Georgopoulos,et al. Escherichia coli DnaJ and GrpE heat shock proteins jointly stimulate ATPase activity of DnaK. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[41] Young-Gyu Ko,et al. Heat Shock Protein 70 Inhibits Apoptosis Downstream of Cytochrome c Release and Upstream of Caspase-3 Activation* , 2000, The Journal of Biological Chemistry.
[42] G. Borsani,et al. p53 gene mutations, p53 protein accumulation and compartmentalization in colorectal adenocarcinoma. , 1995, The American journal of pathology.
[43] C. Georgopoulos,et al. The E. coli dnaK gene product, the hsp70 homolog, can reactivate heat-inactivated RNA polymerase in an ATP hydrolysis-dependent manner , 1990, Cell.
[44] J Milner,et al. Modulation by copper of p53 conformation and sequence-specific DNA binding: role for Cu(II)/Cu(I) redox mechanism. , 1995, Oncogene.
[45] F. Neidhardt,et al. Levels of major proteins of Escherichia coli during growth at different temperatures , 1979, Journal of bacteriology.
[46] J. Nylandsted,et al. Selective depletion of heat shock protein 70 (Hsp70) activates a tumor-specific death program that is independent of caspases and bypasses Bcl-2. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[47] M. Sherman,et al. Oncogenic potential of Hsp72 , 1999, Oncogene.
[48] P. Srivastava,et al. Methods of purification of heat shock protein-peptide complexes for use as vaccines against cancers and infectious diseases. , 2001, Methods in molecular biology.
[49] S. H. Kim,et al. T cell lymphoma in transgenic mice expressing the human Hsp70 gene. , 1996, Biochemical and biophysical research communications.
[50] L. Neckers,et al. Mutant conformation of p53 translated in vitro or in vivo requires functional HSP90. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[51] J. Nylandsted,et al. Heat Shock Protein 70 Is Required for the Survival of Cancer Cells , 2000, Annals of the New York Academy of Sciences.
[52] F. Gago,et al. Heat shock protein expression and drug resistance in breast cancer patients treated with induction chemotherapy , 1998, International journal of cancer.
[53] D. Lane,et al. Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. , 1990, The EMBO journal.
[54] B. Kennedy,et al. NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription. , 2000, Genes & development.
[55] G. Wahl,et al. A leucine‐rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking , 1999, The EMBO journal.
[56] David F. Smith,et al. Hop as an Adaptor in the Heat Shock Protein 70 (Hsp70) and Hsp90 Chaperone Machinery* , 1998, The Journal of Biological Chemistry.
[57] R. Morimoto,et al. Regulation of the Heat Shock Transcriptional Response: Cross Talk between a Family of Heat Shock Factors, Molecular Chaperones, and Negative Regulators the Heat Shock Factor Family: Redundancy and Specialization , 2022 .
[58] G. Wahl,et al. p53 regulation by post-translational modification and nuclear retention in response to diverse stresses , 1999, Oncogene.
[59] Su-mi Han,et al. Truncated Form of Importin α Identified in Breast Cancer Cell Inhibits Nuclear Import of p53* , 2000, The Journal of Biological Chemistry.
[60] D. Notterman,et al. Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. , 2000, Genes & development.
[61] K. McLure,et al. p53 DNA binding can be modulated by factors that alter the conformational equilibrium , 1999, The EMBO journal.
[62] L. Bracco,et al. Proteolysis by calpains: a possible contribution to degradation of p53 , 1997, Molecular and cellular biology.
[63] J. Höhfeld,et al. The Ubiquitin-related BAG-1 Provides a Link between the Molecular Chaperones Hsc70/Hsp70 and the Proteasome* , 2000, The Journal of Biological Chemistry.
[64] D. Cyr,et al. Protein Folding Activity of Hsp70 Is Modified Differentially by the Hsp40 Co-chaperones Sis1 and Ydj1* , 1998, The Journal of Biological Chemistry.
[65] Richard I. Morimoto,et al. 1 Progress and Perspectives on the Biology of Heat Shock Proteins and Molecular Chaperones , 1994 .
[66] M. Jäättelä,et al. Hsp70 exerts its anti‐apoptotic function downstream of caspase‐3‐like proteases , 1998, The EMBO journal.
[67] C. Georgopoulos,et al. ATP Hydrolysis Is Required for the DnaJ-dependent Activation of DnaK Chaperone for Binding to Both Native and Denatured Protein Substrates (*) , 1995, The Journal of Biological Chemistry.
[68] A. Levine,et al. Functions of the p53 protein in growth regulation and tumor suppression. , 1994, Cold Spring Harbor symposia on quantitative biology.
[69] J. Milner,et al. Addition of fresh medium induces cell cycle and conformation changes in p53, a tumour suppressor protein. , 1990, Oncogene.
[70] I. Tohnai,et al. Interaction between hsp70 and hsp40, eukaryotic homologues of DnaK and DnaJ, in human cells expressing mutant‐type p53 , 1995, FEBS letters.
[71] G. Evan,et al. Proliferation, cell cycle and apoptosis in cancer , 2001, Nature.
[72] U. Moll,et al. Cytoplasmically “Sequestered” Wild Type p53 Protein Is Resistant to Mdm2-mediated Degradation* , 1999, The Journal of Biological Chemistry.
[73] M. Mayer,et al. Molecular Basis for Interactions of the DnaK Chaperone with Substrates , 2000, Biological chemistry.
[74] J. Milner,et al. Correlation between the conformational phenotype of p53 and its subcellular location. , 1992, Oncogene.